MindWalk Discovers Universal Influenza Constraint with HYFT Technology

MindWalk Holdings Corp. announced an advance in its universal influenza program following the identification of a breakthrough functional constraint that persists across influenza viruses despite continual evolution. The company used its patented HYFT Deep Data technology to identify a functional pattern embedded in influenza biology that remains intact beneath surface-level genetic change. This breakthrough has the potential to revolutionize the development of universal influenza vaccines.